MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Court upholds NUVA patent win over MDT | Medtech legal news for the week of April 20, 2015

Court upholds NUVA patent win over MDT | Medtech legal news for the week of April 20, 2015

By

Appeals court upholds NuVasive patent win over Medtronic

April 15, 2015 by Brad Perriello

YYmeta

A federal appeals court yesterday dealt Medtronic a 2nd blow in nearly as many weeks when it upheld a U.S. Patent & Trademark Office decision that a NuVasive patent is valid.

The U.S. Court of Appeals for the Federal Circuit affirmed the PTO’s Patent Trial & Appeal Board’s validity ruling without comment, according to court records. Medtronic asked the PTO for an inter partes review of patent no. 7,582,058, “Surgical access system and related method,” back in 2009. Read more

Appeals court won't revisit Bard's $1B win over W.L. Gore

April 13, 2015 by Brad Perriello

Appeals court won't revisit Bard's $1B win over W.L. Gore

W.L. Gore & Assoc. is on the hook for nearly $1.1 billion in damages owed to C.R. Bard after a federal appeals court last week nixed its bid to reconsider part of the case.

Last January the U.S. Court of Appeals for the Federal Circuit upheld a judgment of willful infringement against Gore, tacking on an extra $205 million to the $854 million Gore already owed Bard for trespassing its stent graft patents. Read more

Ex-Boston Scientific engineer cops to stealing catheter secrets

April 15, 2015 by Brad Perriello

Ex-Boston Scientific engineer cops to stealing catheter secrets

A former engineer at Boston Scientific reportedly pleaded guilty to a single count of stealing trade secrets from the medical device maker’s cardiac catheter line.

Aaron Quoc Khieu worked for Boston Scientific at its Maple Grove, Minn., facility as an engineer working on new catheter products, according to court documents. Khieu allegedly stole more than 100 documents covering the specs for Boston Scientific’s Sapphire and Mustang catheters, plus the documentation covering an as-yet unreleased product, according to the indictment. The name of the 3rd catheter is still under seal, according to the documents. Read more

AngioDynamics wants court to enforce $160m Biolitec judgment

April 13, 2015 by Brad Perriello

AngioDynamics wants court to enforce $75m Biolitec judgment

AngioDynamics wants a federal court judge in Massachusetts to enforce its $160 million judgment against German medical laser maker Biolitec.

Judge Michael Ponsor of the U.S. District Court for Massachusetts slapped Biolitec with a $75 million ruling last year, after finding that it deliberately effected a so-called “downstream merger” to move its incorporation to Austria to escape jurisdiction in U.S. courts. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]
  • New method of cardiac ablation used in first in-human trial for ventricular tachycardia
    A new cardiac ablation technique for patients with ventricular tachycardia (VT) has been used in its first in-human multicenter trial involving Mayo Clinic. The new process — needle ablation using in-catheter, heated, saline-enhanced, radio frequency (SERF) energy — creates lesion scars inside the heart muscle where life-threatening arrhythmias cause VT, Mayo Clinic said. Injecting heated saline… […]

Leave a Reply